MRI contrast agents and nephrogenic systemic fibrosis: why physicians should be concerned

Authors

  • PK Chhetri Assistant Professor, Department of Radiodiagnosis, College of Medical Sciences, Bharatpur, Chitwan district

DOI:

https://doi.org/10.3126/jcmsn.v6i1.3606

Keywords:

MRI contrast, computed tomography, nephrogenic systemic fibrosis

Abstract

Magnetic Resonance Imaging (MRI) as a diagnostic tool is becoming increasingly available in Nepal and more and more patients undergo MRI examination today. It was also traditionally believed that MRI contrast agents are safer than Computed Tomography (CT) contrast agents and MRI was indicated where CT contrast agents were contraindicated. Of special note must be made of a rare and newly recognized disease that was described in patients with renal disease and given MRI contrast agents. It is thus of increasing importance for the radiologists and the physicians alike to be aware of this rare and newly recognized disease - nephrogenic systemic fibrosis.

Key words: MRI contrast; computed tomography; nephrogenic systemic fibrosis.

DOI: 10.3126/jcmsn.v6i1.3606

Journal of College of Medical Sciences-Nepal, 2010, Vol. 6, No. 1, 63-66

Downloads

Download data is not yet available.
Abstract
661
PDF
523

Downloads

How to Cite

Chhetri, P. (2010). MRI contrast agents and nephrogenic systemic fibrosis: why physicians should be concerned. Journal of College of Medical Sciences-Nepal, 6(1), 63–66. https://doi.org/10.3126/jcmsn.v6i1.3606

Issue

Vol. 6 No. 1 (2010)

Section

Review Articles

License

This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.